| Basics |
DexCom, Inc.
DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
|
| IPO Date: |
April 14, 2005 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$27.35B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.73 | 2.05%
|
| Avg Daily Range (30 D): |
$1.23 | 1.77%
|
| Avg Daily Range (90 D): |
$1.22 | 1.59%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.02M |
| Avg Daily Volume (30 D): |
4.74M |
| Avg Daily Volume (90 D): |
3.67M |
| Trade Size |
| Avg Trade Size (Sh.): |
72 |
| Avg Trade Size (Sh.) (30 D): |
67 |
| Avg Trade Size (Sh.) (90 D): |
60 |
| Institutional Trades |
| Total Inst.Trades: |
18,927 |
| Avg Inst. Trade: |
$7.22M |
| Avg Inst. Trade (30 D): |
$7.01M |
| Avg Inst. Trade (90 D): |
$7.21M |
| Avg Inst. Trade Volume: |
.13M |
| Avg Inst. Trades (Per Day): |
5 |
| Market Closing Trades |
| Avg Closing Trade: |
$23.49M |
| Avg Closing Trade (30 D): |
$53.08M |
| Avg Closing Trade (90 D): |
$46.72M |
| Avg Closing Volume: |
344.42K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$1.45
|
$.46
|
$.27
|
|
Diluted EPS
|
$1.43
|
$.45
|
$.27
|
|
Revenue
|
$ 4.3B
|
$ 1.16B
|
$ 1.04B
|
|
Gross Profit
|
$ 2.53B
|
$ 688.8M
|
$ 589M
|
|
Net Income / Loss
|
$ 571.5M
|
$ 179.8M
|
$ 105.4M
|
|
Operating Income / Loss
|
$ 687.2M
|
$ 212.6M
|
$ 133.7M
|
|
Cost of Revenue
|
$ 1.77B
|
$ 468.3M
|
$ 447M
|
|
Net Cash Flow
|
$ 219.8M
|
$ 254.2M
|
$ 298.8M
|
|
PE Ratio
|
49.68
|
|
|
|
|
|
